Acinetobacter baumannii is a Gram-negative ESKAPE microorganism that poses a threat to
public health by causing severe and invasive (mostly nosocomial) infections linked with high …

Being a multidrug-resistant and an invasive pathogen, Acinetobacter baumannii is one of
the major causes of nosocomial infections in the current healthcare system. It has been …

[编者按] 鲍曼不动杆菌已成为21 世纪临床重要致病茵. 鲍曼不动杆菌基因组研究发现其具有快速
获得和传播耐药性的能力, 多重耐药, 广泛耐药, 全耐药鲍曼不动杆菌已呈世界性流行 …

目的了解国内不同地区14 所医院临床分离菌对常用抗菌药物的耐药性. 方法国内不同地区14
所教学医院(12 所综合性医院, 2 所儿童医院) 临床分离菌采用K—B 法按统一方案进行细菌药物 …

Due to the rapid emergence of antibiotic-resistant bacteria, there is a growing need to
discover new antibiotics. To address this challenge, we trained a deep neural network …

Bloodstream infection (BSI) organisms were consecutively collected from> 200 medical
centers in 45 nations between 1997 and 2016. Species identification and susceptibility …

Introduction Despite evidence of the high prevalence of antibiotic resistant infections in
developing countries, studies on the clinical and economic impact of antibiotic resistance …

Acinetobacter baumannii (named in honor of the American bacteriologists Paul and Linda
Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial …

Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible
for hospital-acquired nosocomial infections in the modern healthcare system. Due to the …

Antibiotic resistance is the most challenging clinical and public health problem. Despite of
living in the era of novel technologies in biomedical research, many of untreatable infectious …